Philip Morris
Application for Research Grant Bioassay of Tobacco Smoke Condensates and Related Problems
Fields
- Author
- Homburger, F.
- N, B.J.
- Area
- JOHN-WARE,JUDY/SHB FILE ROOM
- Type
- FORM, FORM
- BUDG, BUDGET/BUDGET REVIEW
- LIST, LIST
- SREP, SCIENTIFIC RESEARCH PROPOSAL
- BUDG, BUDGET/BUDGET REVIEW
- Site
- R22
- Request
- Stmn/R1-037
- Stmn/R1-057
- Named Organization
- Bio, Bio Research Labs,Bio Research Consultants
- Caf
- Crl, Charles River Breeding Lab
- Croton Oil
- Ctr, Council for Tobacco Research
- Cummington Street
- Elsevier Pub
- Jax
- J Nat Cancer Inst
- Ma Inst of Technology
- Millerton
- Proc Soc Exp Biol Med
- Swiss
- Anal Chem
- Atc
- Caf
- Named Person
- Berwald
- Bock
- Croninger
- Cruickshank
- Falk
- Gabliks, J.
- Graham
- Hockett
- Homburger, F.
- Jacobson
- Kensler
- Kotin
- Loosli
- Nettleshid
- Pattison, F.L.
- Reimann
- Sachs
- Sheehan
- Smith
- Snell
- Sommers
- Wynder
- Bock
- Document File
- 1003546610/1003547082/Meeting Scientific Advisory Board 670923 670924 Book 1 of 1
- Litigation
- Stmn/Produced
- Author (Organization)
- Bio, Bio Research Labs,Bio Research Consultants
- Ctr, Council for Tobacco Research
- Master ID
- 1003546610/7082
Related Documents:- 1003546610-7082 Meeting Scientific Advisory Board 670923 670 924 Book 1 of 1
- 1003546613-6616 Confidential Report Scientific Advisory Board Meeting New York, New York 670520 670521
- 1003546617-6619 Administrative Actions
- 1003546620-6622 Applications to Be Considered
- 1003546623-6627 Current Grants by Subject
- 1003546628-6633 Current Grants by Activation
- 1003546634 Renewals
- 1003546635-6636 Renewal Application From Herbert Mckennis, Jr., Ph.D. - No. 223-R8.
- 1003546637-6638
- 1003546639-6659 Application for Research Grant Factors Controlling the Biological Disposition of Pyridine Compounds of Tobacco Smoke
- 1003546660-6661 Application for Renewal and Extension From George O. Gey, M.D. - No. 361-R4.
- 1003546662-6681 Application for Research Grant Continuation of Studies on Characteristic of Normal Cell Growth in Relation to Invasive Carcinoma, Embryonal to Adult Forms. Support of Fellowships.
- 1003546682-6683 Renewal Application From Frederik B. Bang, M.D. - No. 409-R3
- 1003546684-6688 Application for Research Grant Pathogenesis of Virus Infections of Respiratory Mucosae
- 1003546689-6691 A Renewal Application From Charles L. Rose, A.M. And Benjamin Bell, M.D. - #455r1 .
- 1003546692-6701 Application for Research Grant Supplementary Assistance to the Normative Aging and Longevity Study.
- 1003546702-6703 Renewal Grant Application From Oswald Jones, M.D. - No. 523r1.
- 1003546704-6705
- 1003546706-6716 Application for Research Grant
- 1003546717-6718 Renewal Application From Gilbert H. Friedell, M.D. - No. 558-M-R1.
- 1003546719-6722 Application for Renewal of Research Grant the Pathogenesis of Human Bladder Cancer
- 1003546723-6725 the Pathogenesis of Human Bladder Cancer
- 1003546726-6727 A Renewal Application From Geoffrey L. Brinkman, M.D. - No. 561r1.
- 1003546728-6743 Application for Renewal of Research Grant the Effect of Cigarette Smoking on the Ultramicroscopic Structure the Bronchial Mucosa
- 1003546744-6745 A Renewal Application From Kenneth M. Lynch, M.D., and Forde A. Mciver, M.D. - No. 566-R1.
- 1003546746-6751 Application for Renewal of Research Grant Evironmental Factors and Pulmonary Carcinogenicity
- 1003546752-6753 Renewal Application From Lucio Severi, M.D. - No. 567-R1.
- 1003546754-6762 Application for Renewal of Research Grant An Approach to the Study of Internal Factors in Lung Carcinogenesis. Influence of Hormones.
- 1003546763-6764 A Renewal Application From Kenneth M. Moser, M.D. - No. 569-R1.
- 1003546765-6774 Application for Renewal of Research Grant Smoker-Non-Smoker Differencer in Activation of Fibrinolytic-Coagulation Systems.
- 1003546775-6776 First Renewal Application From Clayton G. Loosli, M.D. - No. 573r1.
- 1003546777-6780 Application for Renewal of Research Grant Lung Tissue Reactions to Airborne Chemical and Biological Agents
- 1003546781-6783 Request for A Supplementary Grant From Freddy Homburger, M.D. - No. 456r2.
- 1003546784 Application for Research Grant
- 1003546785-6786 Request for Supplementary Grant From Thomas C. Westfall, A.B., M.S., Ph.D. - No.467r2-S.
- 1003546787-6810 Application for Research Grant Supplemental Grant Request
- 1003546811-6813 A Modified Proposal From Ernest Clark,Ph.D. And Donald B. Giddon, D.M.D., Ph-D.-No. 613-M.
- 1003546814-6817 Application for Renewal of Research Grant A Psychophysiological Study of the Act of Reaching for A Cigarette.
- 1003546818 Request for Grant Supplement From John E. Craighead, M.D. Of Harvard Medical School - No. 550-S.
- 1003546819-6820
- 1003546821-6823 New Research From Freddy Homburger - No.338-A.
- 1003546833-6834 New Application From Walter Redisch, M.D. - No. 626.
- 1003546835-6850 Application for Research Grant (the Effect of Cigarette Smoking on Peripheral Blood Flow in Patients with Essential Hypetension, Untreated and Treated)
- 1003546851-6859 Application for Research Grant Effects of Tobacco Smoking and Nicotine on the Central Nervous System
- 1003546860-6864 New Grant Application From Jack P. Strong, M.D. - #632.
- 1003546865-6867
- 1003546868-6878 Application for Research Grant Relationship of Smoking and Other Environmental Factors to Atherosclerotic Lesions
- 1003546879 Relationship Between Smoking Habits and Coronary Atherosclerosis in Autopsied Males
- 1003546880-6882
- 1003546883
- 1003546884 the 39th Scientific Session of the American Heart Association, New York City, 661021-661028. Also the American Society for the Study of Arteriosclerosis and the Council on Arteriosclerosis of the American Heart Association, 661019 - 661020
- 1003546885-6886
- 1003546887
- 1003546888-6889
- 1003546890
- 1003546891-6893
- 1003546894-6896 A New Grant Application From John R. Rowlands,Ph.D. - No. 611.
- 1003546897-6905 Application for Research Grant Senior Research Scientist
- 1003546906-6912
- 1003546913
- 1003546914-6925 Proposal 5-4727a for Esr Studies of Biochemical Effects of Atmospheric Pollutants
- 1003546926-6946 the Effects of Tobacco Smoke on Lung Tissue As Measured by Electron Spin Resonance
- 1003546947-6948 New Grant Application From Irving Geller, Ph.D. - No. 622.
- 1003546949-6961 Application for Research Grant Effects of Nicotine on Learning in Laboratory Animals
- 1003546962-6963 New Grant Application From Walter B. Essman, Ph.D. - No 623
- 1003546964-6974 Application for Research Grant Studies of Nicotine Action Upon Memory Consolidation
- 1003546975-6977 New Grant Application From John E. Noakes, Ph.D. - No. 624.
- 1003546978-6995A Application for Research Grant 'po-210 in Tobacco'
- 1003546996-6997
- 1003546998-7007 Application for Research Grant Nicotine Effect Upon Cardiac Membrane Enzymes
- 1003547008-7015 Supplement to Application for Research Grant the Council for Tobacco Research Nicotine Effect Upon Cardiac Membrane Enzymes
- 1003547016-7018 New Grant Application From Fritz K Beller, Md., SC.D. - 627.
- 1003547019-7030 Application for Research Grant the Influence of Tobacco Smoking on Intravascular Protelysis
- 1003547031-7032 New Grant Application From Theodore N. Finley, M.D. And Aaron J. Ladman, Ph.D. -No. 628.
- 1003547033-7042 Application for Research Grant Effect of Cigarette Smoking on Lipids and Morphology of Alveolar Lining Material and Macrophages
- 1003547043-7044 New Grant Application From Carlton K. Erickson, Ph.D. - No. 629.
- 1003547045-7054 Application for Research Grant Mechanism of Learning Facilitation by Nicotine
- 1003547055-7056 New Grant Application From Mary Stearns Parshley, Ph.D. - No. 630.
- 1003547057-7069 Application for Research Grant Effects of Constituents of Tobacco Smoke on Normal and Malignant Human Respiratory Epithelium in Vitro.
- 1003547070-7071 Equipment Grant Application From Savl Boyarsky, M.D. Of Duke University Medical School - No. 633.
- 1003547072-7082 Application for Research Grant Nicotine Effect on Ureter in Man: A Possible Therapy for Hydronephrosis.
- Characteristic
- EXTR, EXTRA
- ILLE, ILLEGIBLE
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- qgw02a00
Document Images
1 I I
BIOASSAY, CARCINOGENESIS and TISSUE CULTURE
Dr. Reimann
Date: August 18th, 1967
DDr. Loosli Application For Researc6 Grant five year plan.
Dr. Jacobson #456 is concurrent on a
OP
1
1
N
Dr. Sommers, Chm. Ig'M' ; 0 7 #224 - 1955 - 1902 mc1.
SucCFSSOR TO THE and.enewed annually thryu
_ TOBACCO IIVDUSTRY RESEARCH CO~VthfIYTEE October 1; 1966. '` yv'-
. ~~qh, If! ~
COMt+II]TTEE: 03s irulzv avr:~~u~: Preceded by #29B, #2].2 &
E V
N Y
0
/
1. Name of Investigator: Freddy Homburger, M. D.
President and Director
Bio-Research Institute, Inc.
9 Commercial Avenue
Cambridge, Massachusetts 02141
4. Project or Subject: BIOASSAY OF TOBACCO SMOKE CONDENSATES AND
RELATED PROBLEMS
5. Detailed Plan of Procedure (Use additional pages if more space is required.)
INTR ODUCTION
It is realized that our current grant from CTR has been made
for one year without further commitment in order to enable us to conclude a
five-year program initiated late in 1962.
The present application is to request the Council to consider
support for another five-year program, based upon our past performance sum-
marized in the progress report.
The three major projects for which we seek long-term support
are the following:
1. Acceleration of growth of chemically induced tumors for the
purpose of developing rapid carcinogen testing methods.
2. Systematic study of inhibitors of chemical carcinogenesis
with the aim to neutralize alleged carcinogens contained in cigarette smoke
condensates.
'~ '
#
. . ,
Cf
33
THB COUNCIL FOR TOBACCO RESEARCH - U.S. . Activated on 1011/62
.:..i.::: ~~.. ..: .

Bioassay of Tobacco Smoke Condensates and Related Problems
conditions the decline of carcinogenicity and of co-carcinogenicity for mouse:
"skin that appears to have occurred since 19'60 in cigarette smoke condensate.
entific knowledge and will contribute to the technology necessary to formulate ``;~
. ,,~
3. Skin-painting studies in mice to measure under cornparable ''
Each of these projects is based on many years of experience
in the particular field and clearly promises to yield valuable fundamental sci-
cigarettes that will produce smoke condensates incapable of producing cancers
when paintea on the slein oi mice.
1) Acceleration of Carcinogen Testing
Th
ff
d
i
l
ere are e
orts un
erway
n many
aboratories to develop rapid
screening procedures for the detection of carcinogenic substances. These range
from in vitro tissue culture work to the use_ of neonatal mice, newts and~ other `~`~ff'Kr
tion sites represent the first significant step in this direction. We believe that
it will be possible to obtain even. shorter times of' latency than so far possible
by extracting from the initial carcinogen-injection or -application sites large
numbers of transformed cells for transfer into fresh hosts,
time to make it practical to detect even weak cancer-causing chernicals.
Our studies on the transfer of multiple pooled carcinogen injec-
light for paramecia and other biological phenomena have been, correlated with
carcinogenic potency. However, the most reliable carcinogenesis test would
still be the production of tumors in, a mammalian species in a sufficiently short
species. The destruction of sebaceous glands and the increased lethality of U. V.
Initial experiments on this subject are. already und'erway. The
subcutaneous injection sites of C57BL/6 mice are excised after 3 to 5 weeks of
contact with carcinogen (benzo[rst]pentaphene is being used as standard car-
cinogen) and after mechanical dispersion by means of Snell's cytosieve, the cell
suspensions are centrifugated in Ficoll®, a neutral high molecular dextran-like
polysaccharide of low osmotic pressure. The cells are thereby separated ac-
cording to their specific gravity and the various cell layers, some of which will
contain concentrated amounts of malignant cells, are injected' into fresh hosts.
By this method, it is possible to inject into a single mouse many times the
number of transformed cells coming from numerous induction sites. -Based on
the studies of several authors using transplanted tumors and confirmed by our
own work, the larger the number of transferred' malignant cells, the more
rapid the growth of tumors. It is believed that it may be possible to get a 100%
tumor yield 2 weeks after transfer into new hosts or 5 to 7 weeks after the car-
cinogen was first injected,
1003546825

.Bio-Research Institute, Inc.
Bioassay.of Tobacco Smoke Condensates and Related Problems
in carcinogen injection sites in the subcutaneous tissue five weeks after in ~'
.4.
jection of carcinogen. By transfer of pooled multiple injection sites, we were
~observing changes in from 2 to 3 weeks after carcinogen injection but not
earlier. Thus, the shortest theoretically possible test period would be 4 weeks
In the mouse, the first cytologically malignant cells are found
In hamsters, on the other hand, Nettleship and Smith (Proc. Soc.
Exp. Biol. Med. 74:800-802, 1950) showed morphologically transformed' fibro-
possible test period wouldi be 2 to 3 weeks.
I
transfers could be made 1 or 2 days after injection of carcinogen and the shortest
trates, will produce palpable tumors in a shorter period than in mice. Such
that Nettleship's observations can be confirmed) that transfer of multiple injec-
tion sites in hamsters and even more so, transfer of transformed cell concenl-.
cutaneously induced tumors -is the same as in mice. It is likely (assuming
blasts 24 hours after injection of methylcholanthrene. Hence, it would appear
that the subcutaneous tissue of hamsters would lend itself even better than that
of the mouse to carcinogen testing. The times of latency in hamsters for sub-
and tumor cells transferred fronn, females into males could be identified as be-
longing to the original female host and hence as induced by the carcinogen in-
jected into the first (female) host.
In addition, chromosome studies are readily feasible in hamsters
Institute of Technology, and to carry out the above described studies.
Dr. Janis Gabliks, currently Associate Professor of Cell Biology at Massachusetts
culture laboratory under the direction (either part time or later on full time) of
. We propose to establish during the next 2 to 3 years a tissue
.transfer large numbers of cells exposed to carcinogens in vitro back into ham-
ster cheek pouches. In this way, it may be possible to obtain tumor growth
even more rapidly than is possible with in vivo systems alone.
' In addition, it will then become possible to extend the work of
Berwald and Sachs on transformation of hamster fibroblasts in vitro and to
serial transplantation.
We are quite confident that these techniques applied to subcutaneous
tissue, epidermis and lung tissue of mice and hamsters will make such pro-
cedures as mouse-skin painting obsolete and replace them by carcinogen tests
lasting less than two months and having as endpoints histologically demonstrable
malignant tumors, the truly neoplastic nature of which can be ascertained by
1003546826
While these studies will initially be done wit'h, chemical carcino-
gens (strong, weak and intermediate), we shall soon be able to apply them as

Bio-Research Institute, Inc.
C
Bioassay of Tobacco Smoke Condensates, and Related Problems
tion later this summer and condensate will be available in adequate amounts. ~
Bio-Research Consultants, originally scheduled for this spring, will be in opera-
well to tobacco srnoke condensates, since the condensate producing machine of
found that oxidative derivatives also have this effect.
2) Systematic Study of Inhibitors of Chemical Carcinogenesis
. While Falk and Kotin showed that reduction derivatives of poly-
cyclic hydrocarbons inhibit the carcinogenic effect of these hydrocarbons, we
the di-quinone should be more active.
corresponding to the quinones which, if the peroxide hypothesis were correct,
would not possess the chemotherapeutic activity of the quinones. Conversely,
they possess chemotherapeutic (in contrast to merely carcinogenesis inhibiting)
effects. The hypothesis that hydrogen peroxide, which may form from quinones,
is the cytotoxic agent is susceptible to test by synthetizing the aza derivatives
The quinones appear to be a group of special interest because
neutralize the carcinogenic effects (as tested by our own new rapid methods and
by skin painting) of cigarette smoke condensates.
It is the purpose of a systematic study of derivatives of benzo
[rst]pentaphene, of other polycyclic hydrocarbons and of terpenes (such as li-
monene) and their derivatives to find those compounds that are most active in
counteracting the carcinogenic effects of polycyclic hydrocarbons and that are
themselves least carcinogenic. Such compounds could be used eventually to
which are known to be precursors of the cytotoxic quinones in vivo.
test the trifluoroacetyl derivatives of some hydroquinones and their glycyl esters,
In order to render these compounds more volatile and better
suited for use as adjuvants in the tobacco blends, it is suggested to prepare and
IV
-_... I ...._- -1- ,a :v~ .
These compounds are represented by the following examples: ~A
. 0
1. 9, 10-Phenanthrene hydroquinone di~(trifluoroacetate), IV ©
2. 9, 10-Phenanthrene hydroquinone-bis-trifluoroacetylglycyl `~
3. ester, V
3, 4, 9, 10-dibenzpyrene-5, 8-di(trifluoroacetoxy), VI y~
V
VI

Bio-Research Institute, Inc.
Bioassay of Tobacco Smoke Condensates arnd Related Problems
for the volatilization of amino acids (see, for example, Cruickshank and Sheehan
easily, and the Trifluoroaceti~c acid~ and its derivatives are completely non-Jtoxic~
Anal. Chem. 36:1191, 1964). The trifluoroacetate group is known to split ver-
and physiologically inert (see "Toxic Aliphatic Fluorine Compounds" by F. L;
Pattison, Elsevier Pub. Co. , 1959', pp. 20;27;62).
Skin-Painting Studies in Mice
genicity of smoke condensates,
and Wynderts early work, for lack of a better method, as a measure of carcino-'
Skin painting in mice has been used since Croninger, Graham
control for a comparison between mouse carcinogenicity of condensates of 1960
in 1960 of cigar tobacco which have been preserved and which could serve as a",
earlier (more carcinogenic) experiments. We have some 20, 000 cigarettes made
prepare at the time of his latest study condensates from cigarettes used in his
W'ynder and by Bock. However, neither of these authors was in a position to
duced carcinogenicity of cigarette smoke condensates have been published by
originally studied by Wynder, Kensler and ourselves. Such observations on re=
. ;.,,~...;,..~
This approach is based on methods used in gas chrornatography
There are indications that present day cigarettes may be less car-~.
cmogensc an ess co-carcinogenic in terms of mouse skin response than those ,, zf{
and' of 1967.
The evidence which suggests such an experiment is shown in
Table I, summarizing our own mouse-skin painting experiments using conden-
sates from various unfiltered cigarettes done in 1960, 1963, 64, 65 and 66. ..yR
There is a strong suggestion here that the mouse-skin carcinoizenicity
" has declined and, even more striking, that co-carcinogenicity has practically
disappeared6 While the cigarettes used were the same brand in most of these
studies, the source of the condensates, the machines used for smoking and the
handling of the condensates were different. For these reasons, the results
shown here are only suggestive and not conclusive.
We are convinced, however, that a repetition of our earlier
study sponsored by CTR in 1960 to 61 would yield similar and conclusive evi-
dence if indeed the composition of present day cigarettes has changed. We are
1003546828
Condensates could be prepared by Bio-Research Consultants in
an identical mariner for all cigarettes smoked. Condensates would be diluted
with equal parts of acetone as in our previous studies,
planning the experiment summarized in Table II.

Bioassay of Tobacco Smoke Condensates and R elated~ Problems
By use of the ATC cigarettes (which we obtained from Dr.
40
experiment), we could obtain a check on the reproducibility of' the first (19'60)
;. ~.
Hockett and understand to be made of the cigar tobacco used in our original 1960
experiment and thereby determine that CAF1 mice respond today in a manner.
,
similar to 1960. We could by this device obtain a comparison with the Millerton 7
mice used by Wynder in most of his published studYes. Inclusion of the two most "
..:.:~
widely smoked non-filter cigarettes of today is logical,
condensates.
croton oil as a promotor yields early information on the carcinogenicity of the
. The use of primed animals having received 400y of benzpyrene as
initiator measures the co-carcinogenicity of the condensates, and the use of
ment. It will provide conclusive evidence not obtainable by any other means and
This is an elaborate, complex and protracted (two years) experi-
carcinogenicity of present day cigarettes,
might well demonstrate the absence of co-carcinogenicity and greatly attenuated
come may be predicted! as likely.
In view of our latest skin-painting studies (Table I) such an out-

.
_ able I
SUMMARY OF SOME RECENT '
MOUSE SKIN PAINTING EXPERIMENTS
1
~
Date of beginning of project 1961 -62 . Jan. 1963 May 1964
Mice
0
CAF-1/Jax Millerton Charles River CAF-1/Jax Millerton ,
92 Swiss yg Swiss 29 ~~ Swiss Q$
Millerton~)
Swiss eg
~
N
Primed with benzo[a]pyrenet - - + +
A
9
"5
~rll
Cigarette condensate applied
0
' j
Per cent tar 50% 50% 50% 18. 6% ' 50% ' 50% ` 18, f9Jo 50oJo 18.01 %
5
^ t ~ 1
Per cent water -, - 15.4% - 154oJo -
.
~ ~
No, of mice per group at start 100 200 45 200 150 100 50 50 50 50 00 y c;60
Papillomas after:
. _ . . i . . Y .~~ .
30 weeks
"
56%' 0. 5%
14% ~
40
42 " 1% 10% ~' 58% ~ 8% 0% 0. 2% 0: ~s
'~v
57 " 9% 1% a
66 " 20% 39% 6% 0. 7%
76 " 32% r 60% 12% 21% 7% ~sc
f
Published J. Nat. Cancer Inst. 31:1445, 1963.
4001Ag per mouse.
.~
ocsftscoo-r
,
:;.
.
July 1964 ,. April 1965 Dec. ` 1965 Feb.' 1966' . P.uguet;-196E
~
.
ta+:".'t~~ai;
~rr
.
Q

ME
®
Group
No.
10
11
12
Total
950
:rx+-V"
~
Application Th Council for Tobacco
esearch-U.S.A, s.
Bio-Research Institute, Inc. Table II
~.. s/ . ! . . . . . r,J ~
+~ .
t PROPOSED EXPERIMENT FOR CTR MOUSE SKIN PAINTING
Strain of
Mice
CAF/1
0
No. Mice
per Group
100
,
" 100
Millerton Sw~ss 100
50
50
50
50
Primer
(mg per mouse)
0.4
0.4'
0.4
0.4
Treatment of Mice
Cigarette Smoke Condensate
Derived from
ATCt
Brand A
Br:~ne g
none~
ATCt
ATCt
Brana 13
none
#
Croton Oil
0.75
d
0. 75
~
4
*
Benzo[a]pyrene
#* All cigarettes of regular length (70 mm)
t All-tobacco cigarettes
# Acetone control

rt
Y5 ~
"6. Budget Plan:
Salaries
Expendable Supplies
Other Expenses
Permanent Equipment "" "
Overhead (15% of a, b, c)
4
2/1/68-1/31/69
:~ Anticipated Duration of Work: Five years
f
Based on current level
of endeavor._: ~
, t,...
£;~8 Facilitiesand Staff' Available: The same personnel as in the past will remain active in
'~ "this work," In addition, a new group is being developed for studies on tissue ,
~ 3
~E ~~~`cultures" and hamster oncology in our new Cummington Street annex, It is
~ anticipated that with~ addition of increased staff in the new division for work
with hamsters, some of the mouse work will be reduced so that during each of _~'X
the next five years, the budget for this project will remain approximately the
. ~ . _ . . . ~ .. _;. . ~ : ~:-: : . ~.., : ..~.; ' . . . .. ...... .. . ..'.:~ .. .. -,:r-
~'."~F;i!
.~ -. . . , _ . . , , . .
.v. ..-. .. . . _ ~ . ..
~: - . .~- : ... + . . . . 2. .. . .. ~ . .
n
Additional Requirements: Condensates for the carcinogen inhibition and carcinogen
~.
acceleration studies will be provided by Bio-Research Consultants free of
charge for labor costs only because their smoking machine was developed under
GTR contract. In the case of skin-painting studies where large amounts of con-" *
.~ densate are required, this will have to be purchased by CTR at the cost incurred ~"
A: by necessary addition of technical personnel for the production of these large ~~
'`amounts of condensate. However, it is anticipated' that the new condensate ma-~ -:
~10 Additional Information (Including relation of work to other projects and other sources of
support)
chine will be so
~~ -~i.r .. . .:. . . .. . . - .,,. ,.,'.
the past, it has been possible to share some personnel with much more. efficien '
~` .
W , r 'carcinogenesis studies carried out under National - Institutes than existing:, s_ ~,mok ~ri
ou 'ng
~of Health, National Cancer Institute Research Grant No. CA machines that this cos
,
~~04869. Since this grant has been discontinued, this is no longer will be small.
~~ possible. :.Thus,` support for these studies by CTR is assuming added importance.~
' for us. `°Even with it (at the requested rate), we must reduce our total effort iri
the carcinogenesis field. Without CTR support, we should have drastically to
,.~reduce our efforts in this field in which we have worked since 1948 and for which
34, 760.
5,300,
3,085_
6, 000_
6,472,
Total 55, 617.
the Insti)ution '
. ~3. aYr irl.+T
l
®
0
Y
N
m
we have developed a uniquely competent team.
Signature
Director of Project
ll,
.~ ^
Business Officer of
.w
